COVID-19: a Catalyst for Change for UK Clinical Oncology

C E Coles; Ananya Choudhury; Peter Hoskin; C M Jones; B O'Leary; T W Roques; H Tharmalingam; F A P Yuille

COVID-19: a Catalyst for Change for UK Clinical Oncology

C E Coles, Ananya Choudhury, Peter Hoskin, C M Jones, B O'Leary, T W Roques, H Tharmalingam, F A P Yuille

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Article › peer-review

Abstract

The United Kingdom (UK) has been severely affected by the Coronavirus Disease 2019 (COVID-19) pandemic. As the National Health Service (NHS) has urgently prioritised management of this outbreak, the UK clinical oncology community has had to adapt rapidly to maintain cancer services and training. These unprecedented times have altered countless aspects of cancer care, education and research, providing a legacy that will extend well beyond the pandemic which catalysed them. This editorial focuses on three key themes which distinguish the UK from many other countries.

Original language	English
Journal	International Journal of Radiation: Oncology - Biology - Physics
Publication status	Accepted/In press - 21 Jun 2020

Embargoed Document

COVID_UKeditorial_coles_2020_v2
Accepted author manuscript, 46.3 KB
Embargo ends: 1/01/30

Cite this

@article{65d71da1c76b4971928e01b9fe11b943,

title = "COVID-19: a Catalyst for Change for UK Clinical Oncology",

abstract = "The United Kingdom (UK) has been severely affected by the Coronavirus Disease 2019 (COVID-19) pandemic. As the National Health Service (NHS) has urgently prioritised management of this outbreak, the UK clinical oncology community has had to adapt rapidly to maintain cancer services and training. These unprecedented times have altered countless aspects of cancer care, education and research, providing a legacy that will extend well beyond the pandemic which catalysed them. This editorial focuses on three key themes which distinguish the UK from many other countries.",

author = "Coles, {C E} and Ananya Choudhury and Peter Hoskin and Jones, {C M} and B O'Leary and Roques, {T W} and H Tharmalingam and Yuille, {F A P}",

year = "2020",

month = jun,

day = "21",

language = "English",

journal = "International Journal of Radiation: Oncology - Biology - Physics",

issn = "0360-3016",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - COVID-19: a Catalyst for Change for UK Clinical Oncology

AU - Coles, C E

AU - Choudhury, Ananya

AU - Hoskin, Peter

AU - Jones, C M

AU - O'Leary, B

AU - Roques, T W

AU - Tharmalingam, H

AU - Yuille, F A P

PY - 2020/6/21

Y1 - 2020/6/21

N2 - The United Kingdom (UK) has been severely affected by the Coronavirus Disease 2019 (COVID-19) pandemic. As the National Health Service (NHS) has urgently prioritised management of this outbreak, the UK clinical oncology community has had to adapt rapidly to maintain cancer services and training. These unprecedented times have altered countless aspects of cancer care, education and research, providing a legacy that will extend well beyond the pandemic which catalysed them. This editorial focuses on three key themes which distinguish the UK from many other countries.

AB - The United Kingdom (UK) has been severely affected by the Coronavirus Disease 2019 (COVID-19) pandemic. As the National Health Service (NHS) has urgently prioritised management of this outbreak, the UK clinical oncology community has had to adapt rapidly to maintain cancer services and training. These unprecedented times have altered countless aspects of cancer care, education and research, providing a legacy that will extend well beyond the pandemic which catalysed them. This editorial focuses on three key themes which distinguish the UK from many other countries.

M3 - Article

SN - 0360-3016

JO - International Journal of Radiation: Oncology - Biology - Physics

JF - International Journal of Radiation: Oncology - Biology - Physics

ER -

COVID-19: a Catalyst for Change for UK Clinical Oncology

Abstract

Embargoed Document

Fingerprint

Cite this